BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35723196)

  • 21. Bromodomain protein 4 is a novel predictor of survival for gastric carcinoma.
    Zhu Y; Yang W; Ji G; Lin N; Wu W; Xiong P; Zheng C; Yan L; Wan P; Wang Y
    Oncotarget; 2017 May; 8(19):31092-31100. PubMed ID: 28415703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GPRC5A overexpression predicted advanced biological behaviors and poor prognosis in patients with gastric cancer.
    Liu H; Zhang Y; Hao X; Kong F; Li X; Yu J; Jia Y
    Tumour Biol; 2016 Jan; 37(1):503-10. PubMed ID: 26227221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased HOXC6 mRNA expression is a novel biomarker of gastric cancer.
    Jung J; Jeong S; Jeong H; Oh HE; Choi JW; Lee ES; Kim YS; Kwak Y; Kim WH; Lee JH
    PLoS One; 2020; 15(8):e0236811. PubMed ID: 32745141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
    Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
    Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circular RNA hsa_circ_0000745 may serve as a diagnostic marker for gastric cancer.
    Huang M; He YR; Liang LC; Huang Q; Zhu ZQ
    World J Gastroenterol; 2017 Sep; 23(34):6330-6338. PubMed ID: 28974900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circular RNA and gene expression profiles in gastric cancer based on microarray chip technology.
    Sui W; Shi Z; Xue W; Ou M; Zhu Y; Chen J; Lin H; Liu F; Dai Y
    Oncol Rep; 2017 Mar; 37(3):1804-1814. PubMed ID: 28184940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
    Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
    World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutant NPM1-regulated lncRNA HOTAIRM1 promotes leukemia cell autophagy and proliferation by targeting EGR1 and ULK3.
    Jing Y; Jiang X; Lei L; Peng M; Ren J; Xiao Q; Tao Y; Tao Y; Huang J; Wang L; Tang Y; Yang Z; Yang Z; Zhang L
    J Exp Clin Cancer Res; 2021 Oct; 40(1):312. PubMed ID: 34615546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and clinical significance of long non-coding RNA HNF1A-AS1 in human gastric cancer.
    Dang Y; Lan F; Ouyang X; Wang K; Lin Y; Yu Y; Wang L; Wang Y; Huang Q
    World J Surg Oncol; 2015 Oct; 13():302. PubMed ID: 26472090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. circSMARCA5 Functions as a Diagnostic and Prognostic Biomarker for Gastric Cancer.
    Cai J; Chen Z; Zuo X
    Dis Markers; 2019; 2019():2473652. PubMed ID: 30956729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Centromere Protein I (CENP-I) Is Upregulated in Gastric Cancer, Predicts Poor Prognosis, and Promotes Tumor Cell Proliferation and Migration.
    Wang J; Liu X; Chu HJ; Li N; Huang LY; Chen J
    Technol Cancer Res Treat; 2021; 20():15330338211045510. PubMed ID: 34617858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated long non-coding RNA LINC00958 was associated with metastasis and unfavorable prognosis in gastric cancer.
    Wang W; Song ZJ; Wang Y; Zhong WF; Kang P; Yang Y
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):598-603. PubMed ID: 30720167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced expression of circRNA hsa_circ_001888 in gastric cancer and its clinical significance.
    Shi P; Song H; Ding X
    J Clin Lab Anal; 2021 Sep; 35(9):e23953. PubMed ID: 34398999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TEAD1/4 exerts oncogenic role and is negatively regulated by miR-4269 in gastric tumorigenesis.
    Zhou Y; Huang T; Zhang J; Wong CC; Zhang B; Dong Y; Wu F; Tong JHM; Wu WKK; Cheng ASL; Yu J; Kang W; To KF
    Oncogene; 2017 Nov; 36(47):6518-6530. PubMed ID: 28759040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NEDD9 overexpression correlates with the progression and prognosis in gastric carcinoma.
    Shi R; Wang L; Wang T; Xu J; Wang F; Xu M
    Med Oncol; 2014 Mar; 31(3):852. PubMed ID: 24469954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long noncoding RNA HOXA11-AS promotes gastric cancer cell proliferation and invasion
    Liu Y; Zhang YM; Ma FB; Pan SR; Liu BZ
    World J Gastroenterol; 2019 Jun; 25(22):2763-2775. PubMed ID: 31235999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FTO expression is associated with the occurrence of gastric cancer and prognosis.
    Xu D; Shao W; Jiang Y; Wang X; Liu Y; Liu X
    Oncol Rep; 2017 Oct; 38(4):2285-2292. PubMed ID: 28849183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of PURPL and downregulation of NONHSAT062994 as potential biomarkers in gastric cancer.
    Moridi H; Karimi J; Tavilani H; Khodadadi I; Emami Razavi AN
    Life Sci; 2019 Nov; 237():116904. PubMed ID: 31606380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and Clinical Significance of ILF2 in Gastric Cancer.
    Yin ZH; Jiang XW; Shi WB; Gui QL; Yu DF
    Dis Markers; 2017; 2017():4387081. PubMed ID: 28831206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trim47 overexpression correlates with poor prognosis in gastric cancer.
    Xia Y; Wei Z; Huang W; Wei X; He Y
    Neoplasma; 2021 Mar; 68(2):307-316. PubMed ID: 33350849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.